Rho d immune globulin inj
Products billed under this code include HyperRho S/D, Rhogam.
Payment limit per 300 MCG (1500 IU), by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include HyperRho S/D, Rhogam.
Payment limit per 300 MCG (1500 IU), by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| HyperRho S/D | Grifols USA, LLC | 13533-0631-02 | 1 | $82.081 |
| HyperRho S/D | Grifols USA, LLC | 13533-0631-11 | 10 | $820.81 |
| Rhogam | Kedrion Biopharma Inc | 00562-7805-01 | 1 | $82.081 |
| Rhogam | Kedrion Biopharma Inc | 00562-7805-05 | 5 | $410.405 |
| Rhogam | Kedrion Biopharma Inc | 00562-7805-25 | 25 | $2,052.025 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $82.081 | −$3.044 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted September 17, 2026 |
| 3Q26 | $85.125 | +$6.226 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted September 15, 2026 |
| 2Q26 | $78.899 | −$1.633 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted September 15, 2026 |
| 1Q26 | $80.532 | −$2.043 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted September 15, 2026 |
| 4Q25 | $82.575 | +$0.152 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted September 8, 2026 |
| 3Q25 | $82.423 | +$5.265 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted March 10, 2026 |
| 2Q25 | $77.158 | −$6.204 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted March 10, 2026 |
| 1Q25 | $83.362 | +$3.223 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted December 19, 2025 |
| 4Q24 | $80.139 | +$2.823 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 11, 2025 |
| 3Q24 | $77.316 | −$2.66 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 11, 2025 |
| 2Q24 | $79.976 | −$1.185 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted March 11, 2025 |
| 1Q24 | $81.161 | +$3.865 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted December 19, 2024 |
| 4Q23 | $77.296 | −$4.535 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted October 10, 2024 |
| 3Q23 | $81.831 | +$5.006 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 5, 2024 |
| 2Q23 | $76.825 | −$4.947 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted February 23, 2024 |
| 1Q23 | $81.772 | +$1.367 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted December 6, 2023 |
| 4Q22 | $80.405 | +$0.937 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 22, 2023 |
| 3Q22 | $79.468 | +$0.972 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 9, 2023 |
| 2Q22 | $78.496 | −$0.493 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted December 14, 2022 |
| 1Q22 | $78.989 | +$3.45 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 8, 2022 |
| 4Q21 | $75.539 | −$1.994 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 2, 2022 |
| 3Q21 | $77.533 | −$0.925 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted June 2, 2022 |
| 2Q21 | $78.458 | −$1.903 | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted March 1, 2022 |
| 1Q21 | $80.361 | – | 300 MCG (1500 IU) | Rho d immune globulin inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.